Drug Wars :How Big Pharma Raises Prices and Keeps Generics off the Market

4.04 ( 25 Ratings by Goodreads)
Drug Wars

Drug Wars :How Big Pharma Raises Prices and Keeps Generics off the Market

(Author) (Author)
4.04 (25 Ratings by Goodreads)
hardback
Published: 9 June, 2017
Standard worldwide delivery by Tue, August 25 - Fri, August 28
Order within 0
Condition: NEW
$52.45
Price includes shipping
Available 20+ in stock
- +
Add to basket Wishlist This
FREE Returns within 30 days
More Details

Popular Books by Robin Feldman

View All Books by Robin Feldman
AI versus IP
AI versus IP
Robin Feldman
$46.33
New
Add to basket
Drugs, Money, and Secret Handshakes
Drugs, Money, and Secret Handshakes
Robin Feldman
$73.68
New
Add to basket
The Role of Science in Law
The Role of Science in Law
Robin Feldman
$217.30
New
Add to basket
Drugs, Money, and Secret Handshakes
Drugs, Money, and Secret Handshakes
Robin Feldman
$21.43 $21.59
New
Add to basket
AI versus IP
AI versus IP
Robin Feldman
$123.60 $128.58
New
Add to basket
Rethinking Patent Law
Rethinking Patent Law
Robin Feldman
$80.99
New
Add to basket

Description

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
See more

More Details

Type Book
ISBN13 9781107168480
ISBN10 1107168481
Number Of Pages 160
Item Weight 380 g
Product Dimensions 158 x 235 x 14 mm
Publisher / Reseller Cambridge University Press
Format hardback
See More +

Media Reviews

'An important book and a compelling read. The authors show how pharmaceutical companies have twisted a law designed to protect invention into a regulatory nightmare that only protects profits.' Mark A. Lemley, William H. Neukom Professor, Stanford Law School, California
'A fascinating and incisive study of the inner world of the pharmaceutical industry. A must-read for anyone interested in the relationship between drug pricing, regulation, and its impact on public health.' Sonia K. Katyal, Chancellor's Professor of Law, University of California, Berkeley

Show more

GoodReads Reviews

Author's Bio

Robin Feldman is an award-winning teacher and scholar who has published more than forty articles and books. Feldman has been cited by the White House, members of Congress, and numerous federal agencies, and she has testified before committees of the US House and Senate, as well as the California legislature. In 2016, Feldman was named as one of the Women Leaders in Law and Technology, the only academic to receive the honor. Evan Frondorf's legal work with Robin Feldman has been published in journals at Harvard University, Massachusetts and Stanford University, California, including papers on patent demands and generic pharmaceuticals. He studied economics at Yale University, Connecticut and graduated Phi Beta Kappa and magna cum laude, and he was also named a Rhodes Scholar finalist in 2015. He is the current sportswriter for the Yale Alumni Magazine. At Yale, he was heavily involved in sports broadcasting and served as a deputy sports editor at the Yale Daily News.

Show more